Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Researchers Determine How SARS-CoV-2 Hijacks and Rapidly Damages Human Lung Cells

Dublin-Boston Scoring System Helps Predict Which COVID-19 Patients Will Develop Severe Infection

Autoimmune-Like Antibody Response Linked with Severe COVID-19

by Matthew Woodruff October 10, 2020, 8:30 am
Early Clinical Signs of Severe Lassa Fever

by Global Biodefense Staff October 7, 2020, 12:27 pm
Here’s What We Know So Far About Pediatric Multisystem Inflammatory Syndrome (MIS-C)

by Ritu Banerjee September 10, 2020, 2:08 pm
People with Zika Antibodies More Vulnerable to Severe Dengue Disease

by Global Biodefense Staff August 27, 2020, 8:09 am
What the Archaeological Record Reveals About Epidemics Throughout History

by Charlotte Roberts, Gabriel D. Wrobel, and Michael Westaway June 15, 2020, 5:35 am
NIH Grants to Fund Studies of Parasitic Infections Affecting Millions Worldwide

by Global Biodefense Staff May 24, 2020, 7:22 am
Canadian Team First in World to Treat COVID-19 With Specialized Dialysis

by Global Biodefense Staff May 23, 2020, 7:00 am
What FDR’s Polio Crusade Teaches Us About Presidential Leadership Amid Crisis

by Thomas Doherty, Brandeis University May 12, 2020, 7:56 am
NIH-Funded ‘HEROS’ Study Will Determine Incidence of Novel Infection in U.S. Children

by Global Biodefense Staff May 4, 2020, 1:20 pm
COVID-19 Study Shows That Men Have Over Double the Death Rate of Women

by Global Biodefense Staff April 29, 2020, 7:00 am
Tool Monitors Flu Mutations in Real Time

by Global Biodefense Staff February 24, 2020, 6:03 pm
NIH Study Supports New Approach for Treating Cerebral Malaria

by Global Biodefense Staff February 19, 2020, 11:24 am
MSF Update on Ebola Frontline Response

by Global Biodefense Staff January 20, 2020, 1:22 pm
Hundreds Dead as Yemen Flu Outbreak Spreads

by By Adel Aldaghbashy, SciDev.Net January 17, 2020, 12:47 pm

Congratulations. You've reached the end of the internet.

Infectious Diseases

Researchers Determine How SARS-CoV-2 Hijacks and Rapidly Damages Human Lung Cells

Dublin-Boston Scoring System Helps Predict Which COVID-19 Patients Will Develop Severe Infection

Autoimmune-Like Antibody Response Linked with Severe COVID-19

Early Clinical Signs of Severe Lassa Fever

Here’s What We Know So Far About Pediatric Multisystem Inflammatory Syndrome (MIS-C)

People with Zika Antibodies More Vulnerable to Severe Dengue Disease

What the Archaeological Record Reveals About Epidemics Throughout History

NIH Grants to Fund Studies of Parasitic Infections Affecting Millions Worldwide

Canadian Team First in World to Treat COVID-19 With Specialized Dialysis

What FDR’s Polio Crusade Teaches Us About Presidential Leadership Amid Crisis

NIH-Funded ‘HEROS’ Study Will Determine Incidence of Novel Infection in U.S. Children

COVID-19 Study Shows That Men Have Over Double the Death Rate of Women

Tool Monitors Flu Mutations in Real Time

NIH Study Supports New Approach for Treating Cerebral Malaria

MSF Update on Ebola Frontline Response

Hundreds Dead as Yemen Flu Outbreak Spreads

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest Articles

More Infectious Disease News